DoW Breast Cancer, Breakthrough Award Level 3

The fiscal year 2026 Breast Cancer Research Program (BCRP) Breakthrough Award mechanism supports promising research with high potential to lead to or make breakthroughs in breast cancer. The program announcement discusses the Breakthrough Award Level 3, which allows for small-scale clinical trials but does not require them. The research team must include two or more breast cancer consumer advocates, and the funding mechanism allows for a single Principal Investigator (PI) or two partnering PIs. The estimated funding for this opportunity is $12,600,000, and the award ceiling and floor are not specified. Key points to consider: • The opportunity is for a grant to support research in breast cancer. • The research must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception. • The funding mechanism allows for small-scale clinical trials but does not require them. • The research team must include two or more breast cancer consumer advocates. • The opportunity allows for a single Principal Investigator (PI) or two partnering PIs.